MTCO2P24

Across TCGA pan-cancer cohorts, MTCO2P24 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MTCO2P24 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MTCO2P24 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTCO2P24 expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.

UCEC, CESC, and SARC are the cancer types where MTCO2P24 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	II,III,IV	0.094	0.542	.001	108	view →
CESC	OS	Tertile	All	0.181	0.803	<.001	108	view →
SARC	OS	Tertile	All	0.158	0.842	<.001	54	view →
COAD	OS	Tertile	III,IV	0.523	0.796	.007	51	view →
PAAD	OS	Tertile	All	0.037	0.641	<.001	45	view →
THCA	DFS	Tertile	IV	0.027	0.937	<.001	45	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
READ	DFS	Tertile	III,IV	0.059	0.761	<.001	27	view →
GBM	OS	Tertile	All	0.200	0.420	.013	18	view →
LIHC	DFS	Tertile	All	0.086	0.557	<.001	18	view →
PCPG	OS	Tertile	All	0.516	0.947	.009	18	view →
BLCA	DFS	Tertile	III,IV	1.000	0.189	.043	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MTCO2P24–UCEC (OS)

Open the UCEC breakdown →